SXTP (60 Degrees Pharmaceuticals) Total Assets: $6.76 Mil (As of Mar. 2026)


SXTP 60 Degrees Pharmaceuticals Inc SXTP
44 GF Score
Price $1.72
GF Value $2.05
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is 60 Degrees Pharmaceuticals Total Assets?

60 Degrees Pharmaceuticals SXTP -1.71% 44 Total Assets is $6.76 Mil as of Mar. 2026. GuruFocus rates SXTP with a GF Score™ of 44/100 and a GF Value™ of $2.05 (Modestly Undervalued). The stock has 5 warning signs investors should review.

60 Degrees Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2026 was $6.76 Mil.

During the past 12 months, 60 Degrees Pharmaceuticals's average Total Assets Growth Rate was 35.60% per year. During the past 3 years, the average Total Assets Growth Rate was 55.20% per year. During the past 5 years, the average Total Assets Growth Rate was 24.00% per year.

During the past 6 years, 60 Degrees Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 55.20%. The lowest was 32.70%. And the median was 47.40%.

Total Assets is connected with ROA %. 60 Degrees Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2026 was -137.79%. Total Assets is also linked to Revenue through Asset Turnover. 60 Degrees Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2026 was 0.03.

60 Degrees Pharmaceuticals  (NAS:SXTP) Total Assets Explanation

Total Assets is connected with ROA %.

60 Degrees Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-8.356/( (5.366+6.763)/ 2 )
=-8.356/6.0645
=-137.79 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

60 Degrees Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0.162/( (5.366+6.763)/ 2 )
=0.162/6.0645
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

60 Degrees Pharmaceuticals Total Assets Related Terms

60 Degrees Pharmaceuticals Total Assets Historical Data

* Premium members only.

The historical data trend for 60 Degrees Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

60 Degrees Pharmaceuticals Total Assets Chart

60 Degrees Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 1.39 1.30 7.78 5.76 5.37

60 Degrees Pharmaceuticals Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.98 4.18 6.69 5.37 6.76
SXTP
44GF Score
60 Degrees Pharmaceuticals Inc SXTP
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

60 Degrees Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

60 Degrees Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=3.379+1.987
=5.37

60 Degrees Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=4.744+2.019
=6.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $6.76 Mil mean?
60 Degrees Pharmaceuticals (SXTP) has a Total Assets of $6.76 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on 60 Degrees Pharmaceuticals and its competitors.
Is 60 Degrees Pharmaceuticals' Total Assets too high?
60 Degrees Pharmaceuticals' current Total Assets is $6.76 Mil. Overall, 60 Degrees Pharmaceuticals has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 60 Degrees Pharmaceuticals' Total Assets compare to GLMD and FBLG?
60 Degrees Pharmaceuticals' Total Assets of $6.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on 60 Degrees Pharmaceuticals and its competitors. 60 Degrees Pharmaceuticals's current Total Assets is $6.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 60 Degrees Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals (SXTP) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.05, compared to a current price of $1.72 — trading 16.1% below its estimated fair value. The current Total Assets is $6.76 Mil. 60 Degrees Pharmaceuticals' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For 60 Degrees Pharmaceuticals (SXTP), the current Total Assets is $6.76 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 60 Degrees Pharmaceuticals (SXTP) Overvalued in 2026?

Based on GuruFocus' analysis, 60 Degrees Pharmaceuticals stock appears to be undervalued. The current stock price of $1.72 is trading 16.1% below its estimated GF Value™ of $2.05. GuruFocus considers 60 Degrees Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for SXTP:

  • Total Assets: $6.76 Mil
  • GF Value™: $2.05 vs. price of $1.72 (16.1% below fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the SXTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

60 Degrees Pharmaceuticals Business Description

Address 1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
44GF Score

Get the complete analysis for SXTP

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.72
Price
$2.05
GF Value